Vegzelma (bevacizumab-adcd) is used to treat colorectal cancer, lung cancer, glioblastoma, renal cell carcinoma, cervical cancer and ovarian cancer. Vegzelma is a biosimilar for avastin (bevacizumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Vegzelma may be covered by your Medicare or insurance plan.